← Back to Patent Explorer
US4883662A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of increasing natural killer cell population of cancer patients

Assignee: Clinical Biotechnologies Inc
•
Filing: 1987-01-06
•
Granted: 1989-11-28
•
Expires: 2007-01-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An in vivo method is described for increasing the population of Natural Killer (NK) cells in the blood of patients suffering from cancer, such NK cells having known activity against tumor cells. The method broadly involves injecting a specially prepared biologic into the patient's bloodstream and allowing the biologic to activate the patient's immune system so as to achieve a desired NK cell population increase (preferably at least a twofold increase). The biologic is produced by injecting an animal such as a goat with a virus (preferably a normally immunosuppressive Parvovirus) and allowed to react to the virus for a period of time to generate the biologic in its blood serum; blood is then withdrawn from the animal and the serum fraction thereof, containing the desired biologic, can be used in fractionated or more highly purified form.

Inventors

  • 👤 Robert L. Stout

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 16:09
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/08; C07K16/081

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 254 words
An in vivo method of increasing the Natural Killer cell population in the blood of a cancer patient, said method comprising the steps of: injecting a biologic into the bloodstream of said cancer patient, and allowing said biologic to operate therein for a period of time to increase said Natural Killer cell population, said biologic being a glycoprotein and having an apparent molecular weight of above about 100,000 and being derived from the blood of an animal injected with a virus, wherein the aminal's blood containing the biologic is fractionated to separate potentially interfering substances from the biologic, said virus being a feline panleukopenia or canine origin parvo virus and said animal being other than a feline or canine which is a nonpermissive host for the virus, said virus-injected animal being allowed to react to the presence of the virus such that 50 microliters of the animal's serum, when added to an in vitro human white blood cell culture containing 2-4×10 5 white blood cells and followed by three days inclubation at 37° C. under a 5% CO 2 /95% air atmostphere, will give rise to at least about a 50% increase in T-helper and Natural Killer cells in the biologic-supplemented cell culture as compared with an otherwise identical in vitro cell culture having added thereto 50 microliters of serum from a normal animal of the same species as said injected animal, such rise in T-helper and Natural Killer cells being detected by staining with fluorescent-labeled monoclonal antibodies against T-Helper and Natural Killer cells.
Claim 2
Dependent Claim 254 words
An in vivo method of increasing the Natural Killer cell population in the blood of a cancer patient, said method comprising the steps of: injecting a biologic into the bloodstream of said cancer patient, and allowing said biologic to operate therein for a period of time to increase said Natural Killer cell population, said biologic being a glycoprotein and having an apparent molecular weight of above about 100,000 and being derived from the blood of an animal injected with a virus, wherein the aminal's blood containing the biologic is fractionated to separate potentially interfering substances from the biologic, said virus being a feline panleukopenia or canine origin parvo virus and said animal being other than a feline or canine which is a nonpermissive host for the virus, said virus-injected animal being allowed to react to the presence of the virus such that 50 microliters of the animal's serum, when added to an in vitro human white blood cell culture containing 2-4×10 5 white blood cells and followed by three days inclubation at 37° C. under a 5% CO 2 /95% air atmostphere, will give rise to at least about a 50% increase in T-helper and Natural Killer cells in the biologic-supplemented cell culture as compared with an otherwise identical in vitro cell culture having added thereto 50 microliters of serum from a normal animal of the same species as said injected animal, such rise in T-helper and Natural Killer cells being detected by staining with fluorescent-labeled monoclonal antibodies against T-Helper and Natural Killer cells.
Claim 3
Dependent Claim 15 words
The mathod of claim 1, said increase in Natural Killer cells being at least twofold.
Claim 4
Dependent Claim 20 words
The method of claim 1, said animal being selected from the group consisting of goats, horses, sheep, rabbits and monkeys.
Claim 5
Dependent Claim 10 words
The method of claim 3, said animal being a goat.

References Cited (Backward Citations)

EP0089062A2 Cited
US4572834A Cited
US4687665A Cited
US4689222A Cited
US4692332A Cited
US4690915A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-11-27 1993-05-29 1993-11-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-11-27 1997-05-29 1997-11-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-11-27 2001-05-29 2001-11-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag